HPTN Publications

Stoner MCD, Rucinski KB, Edwards JK, Selin A, Hughes JP, Wang J, Agyei Y, Gomez-Olive FX, MacPhail C, Kahn K, Pettifor A . The Relationship Between School Dropout and Pregnancy Among Adolescent Girls and Young Women in South Africa: A HPTN 068 Analysis.

Stoner MCD, Westreich D, Ahern J, Edwards J, Gómez-Olivé FX, Tollman SM, Lippman S, Kahn K, Pettifor A . Modeling Combination Interventions to Prevent Human Immunodeficiency Virus in Adolescent Girls and Young Women in South Africa (HIV Prevention Trials Network 068). Clin Infect Dis. 2021, 73: e1911-e1918

Stranix-Chibanda L, Hamilton EL, Ngo J, Jiao Y, Hanscom B, Choudhury RP, Agyei Y, Piwowar-Manning E, Marzinke M, Delany-Moretlwe S, Mgodi N, Siziba B, Naidoo I, Gati Mirembe B, Kamira B, McCoig C, Adeyeye A, Spiegel HML, Hosek S; HPTN 084-01 Protocol Team . Safety, tolerability, and acceptability of long-acting injectable cabotegravir for HIV prevention in female adolescents (HPTN 084-01): a single-arm, open-label, phase 2b trial. Lancet HIV. 2025, 12: e252-e260

Strathdee SA, Kuo I, El-Bassel N, Hodder S, Smith LR, Springer SA . Preventing HIV outbreaks among people who inject drugs in the United States: plus ça change, plus ça même chose. AIDS. 2020, 34: 1997-2005

Sugarman J, Barnes M, Rose S, Dumchev K, Sarasvita R, Viet HT, Zeziulin O, Susami H, Go V, Hoffman I, Miller WC . Development and Implementation of Participant Safety Plans for International Research with Stigmatised Populations [HPTN 074]. Lancet HIV. 2018, 5: 468-472

Sugarman J, Mayer KH . Ethics and pre-exposure prophylaxis for HIV infection. J Acquir Immune Defic Syndr. 2013, 63: S135-9

Sugarman J, Rose SM, Metzger D . Ethical issues in HIV prevention research with people who inject drugs. Clin Trials. 2014, 11: 239-45

Sugarman J, Stalter R, Bokoch K, Liu T, and Donnell D, Donnell D . Positive Social Impacts Related to Participation in an HIV Prevention Trial Involving People Who Inject Drugs. IRB: Ethics & Human Research. 2015, 37: 17-19